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Abstract
Background: Fibromyalgia syndrome (FMS) is frequently associated
with psychiatric conditions, particularly anxiety. Deficits in contingency
learning during fear conditioning have been hypothesized to increase
anxiety and, consequently, pain sensation in susceptible individuals. The
goal of this study was to examine the relationship between contingency
learning and pain experience in subjects with FMS and rheumatoid
arthritis (RA).
Methods: Fourteen female FMS subjects, 14 age-matched female RA
subjects and 14 age-matched female healthy controls (HCs) were included
in a fear-conditioning experiment. The conditioned stimulus (CS)
consisted of visual signs, the unconditioned stimulus (US) of thermal
stimuli. CS- predicted low-temperature exposure (US), while CS+ was
followed by low or high temperature.
Results: In the FMS group, only 50% of the subjects were aware of the
US–CS contingency, whereas 86% of the RA subjects and all of the HCs
were aware of the contingency. CS+ induced more anxiety than CS- in
RA subjects and HCs. As expected, low-temperature exposure was
experienced as less painful after CS- than after CS+ in these subjects. FMS
subjects did not show such adaptive conditioning. The effects of the type of
CS on heart rate changes were significant in the HCs and the aware FMS
subjects, but not in the unaware FMS subjects.
Conclusions: Contingency learning deficits represent a potentially
promising and specific, but largely unstudied, psychopathological factor in
FMS. Deficits in contingency learning may increase anxiety and,
consequently, pain sensation. These findings have the potential to
contribute to the development of novel therapeutic approaches for FMS.
1. Introduction
Fibromyalgia syndrome (FMS) is characterized by
chronic widespread pain, anxiety, fatigue, cognitive
impairments and depression (Staud, 2006). The most
effective treatments for FMS include behavioural
treatments and psychopharmacological drugs (Thieme
et al., 2006; Lesley, 2009). Therefore, and in contrast
to rheumatoid arthritis (RA) (Schett and Firestein,
2010), central processes seem pathogenically more
important than peripheral processes in FMS (Neeck,
2002), although not all findings in FMS clearly
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support this notion. Despite the growing evidence,
there is a paucity of studies on the neuropsychiatric
mechanisms underlying FMS pathogenesis.
The relationship between FMS and anxiety is par-
ticularly strong (Asmundson and Katz, 2009). In a
community sample of women, subjects with FMS had
a 20-fold increase in current rates of generalized
anxiety disorder than did women without FMS (Karen
et al., 2006). Anxiety disorders appear to precede the
onset of chronic musculoskeletal pain (Asmundson
and Taylor, 1996), and anxiolytic psychological and
pharmacological interventions can reduce the pain
associated with medical procedures (Park et al., 2008).
Experimental studies have confirmed the enhancing
effects of anxiety/fear on pain (Helmstetter and
Bellgowan, 1993; Crown et al., 2000; Rhudy and
Meagher, 2000; Meagher et al., 2001; Neugebauer
et al., 2004; Meulders et al., 2012).
Conditioning, which plays a key role in the physi-
ological and behavioural responses to pain, is an inte-
gral part of several models of chronic pain. These
models, including the operant conditioning model,
aversive emotional conditioning model and fear
avoidance model, emphasize the role of conditioning
in the origin and maintenance of chronic pain
through its role on muscular tension or avoidance of
physical activities (Flor and Turk, 1989; Vlaeyen and
Linton, 2000; Leeuw et al., 2007). In classical condi-
tioning, a previously neutral stimulus (later the con-
ditioned stimulus = CS) paired with a biologically
significant stimulus (unconditioned stimulus = US)
elicits a conditioned response (CR) that resembles the
response to the US, and this is the unconditioned
response (UR). In the fear-conditioning paradigm, a
CS (CS+) is presented together with an aversive US,
while the other stimulus (CS-) is never paired with
the US. Hence, CS+ acquires the same aversive quali-
ties as the US, and the subject learns to fear the stimu-
lus associated with the aversive event. The present
study relied on an expectancy-based model of fear
conditioning to examine the relationship between
contingency learning and pain experience, and it was
based on the following three observations. First,
anxiety induced by pain expectation enhances pain
(Al Absi and Rokke, 1991; Ploghaus et al., 2001).
Second, conditioning is a process by which organisms
learn contingency among stimuli (i.e., the US follows
the CS+ but not the CS-), and they develop expect-
ancies about the occurrence or non-occurrence of
aversive events, which can lead to conditioned fear to
the CS+ (Lovibond and Shanks, 2002). In differential
conditioning experiments in which a CS+ is repeat-
edly paired with an aversive US (e.g., a shock) and a
CS- is never reinforced with the US, the CS+ evokes
aversive expectancy (fear), while the CS- evokes no
aversive expectancy (no fear). Hence, during condi-
tioning, a mildly aversive event is felt as more painful
following a CS+ than a CS-. Third, given the finding
that the development of expectancy during condition-
ing is a learning process (Chan and Lovibond, 1996),
excessive fear may result from a failure to learn the
correct CS–US contingency (Grillon, 2002). Generally,
the inability to correctly learn predictive cues in the
environment leaves the organism in a state of chronic
anxiety because of the inability to identify safety
periods. According to this perspective, contingency
learning deficits may conceivably contribute to hype-
ralgesia in FMS subjects. Fear-conditioning experi-
ments can be used to elicit both hypoalgesia (Flor
and Grösser, 1999; Flor et al., 2002) or hyperalgesia
(Al Absi and Rokke, 1991; Ploghaus et al., 2001).
Whether the experiments elicit hypo- or hyperalgesia
depends on the kind (stress related to the pain or not)
and intensity of the stressor and the experiment dura-
tion (Al Absi and Rokke, 1991; Flor and Grösser,
1999; Rhudy and Meagher, 2000). Thus, to induce
What’s already known about this topic?
• Classical conditioning plays a key role in the
physiological response, subjective feeling and
behavioural response to pain, and, consequently,
conditioning is an integral part of several models
of chronic pains. Such models emphasize the role
of conditioning in the origin and maintenance of
chronic pain via its role on muscular tension or
avoidance.
What does this study add?
• The present study relies on an expectancy-based
model of aversive conditioning to elucidate the
role of anxiety in the pathogenesis of fibromyal-
gia syndrome (FMS) compared to rheumatoid
arthritis. Specifically, the study examined the
role of conditioned fear evoked by expectation of
pain on the experience of pain in FMS.
• Fear-learning deficits in a conditioning experi-
ment as a potentially promising and specific
psychopathological marker in fibromyalgia
syndrome.
• Deficits in fear learning may increase anxiety
and, as a consequence, pain sensation. These
findings have the potential to contribute to the
development of novel therapeutic approaches
for fibromyalgia.
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hyperalgesia in this study, we used pain-related and
relatively mild stressors.
We hypothesized that subjects with FMS would
show deficits in contingency learning, which would
result in excessive fear to the CS- and, therefore, the
exacerbation of pain following the CS-. Hence, we
expected healthy controls (HCs) and subjects with RA
to experience an exposure to low temperature as less
painful after the safety signal CS- than after the
danger signal CS+. However, in FMS subjects, we
expected reduced CS–US contingency learning
(Odling Smee, 1975) that would result in similar levels
of fear and pain after the safety signal (CS-) and the
danger signal (CS+).
2. Methods and materials
2.1 Subjects
Given the predominance of women with FMS (Wolfe et al.,
1995) and to reduce the heterogeneity of the study samples,
we only included women in this study. In order to exclude
the possibility that reactions deviating from those of the HC
group that were found in this study were non-specifically
related to chronic pain conditions rather than to FMS, we
used two control groups, one of which comprised age-
matched healthy women and the other of which comprised
age-matched women with RA because neuropsychiatric
mechanisms are not expected to play major roles in the
pathophysiology of RA. The study sample of 42 female sub-
jects who were aged 18 to 65 years included the three fol-
lowing age-matched diagnostic groups: 14 subjects with
FMS, 14 subjects with RA and 14 HCs. The demographic and
clinical characteristics across the diagnostic groups are pro-
vided in Table 1. Subjects provided written informed consent
after receiving a full explanation of the study purpose, pro-
cedures and risks. The study was approved by the local
ethical committee (Kantonale Ethikkommission Zürich).
2.2 Diagnostic and psychometric assessments
Rheumatologic diagnoses were established according to the
American College of Rheumatology 1990 classification crite-
ria (Wolfe et al., 1990) and the criteria for the classification
Table 1 Demographic and clinical characteristics of subjects with ﬁbromyalgia (n = 14), healthy controls (n = 14) and rheumatoid arthritis (n = 14).
Variable
Fibromyalgia Healthy control Arthritis
p*Mean SD Mean SD Mean SD
Age 48.8 9.1 48.9 4.7 54.5 6.5 n.s.
State-Trait Anxiety Inventory
State 47.2 14.3 33.3 5.6 33.6 5.7 <0.001
Trait 46.3 11.9 32.8 6.6 32.9 5.7 <0.001
Beck Depression Inventory 17.0 10.2 4.1 2.8 7.0 4.8 <0.001
Pain Disability Index 41.1 12.9 2.7 3.4 17.1 12.1 <0.001
n % n % n %
Education
No completed 3 21.4 0 0.0 0 0.0 n.s.
Apprenticeship 9 64.3 9 64.3 11 78.6
College/university 2 14.3 5 35.7 3 21.4
Occupational invaliditya
No 6 42.9 14 100.0 11 78.6 <0.01
Yes (complete or partial) 8 57.1 0 0.0 3 21.4
Any psychiatric diagnosisb 8 57.1 0 0.0 2 14.3 <0.01
Major depressive disorder 3 21.4 0 0.0 1 7.1
Any anxiety disorder 7 50.0 0 0.0 2 14.3
Panic disorder 3 21.4 0 0.0 1 7.1
Agoraphobia 3 21.4 0 0.0 1 7.1
PTSD 3 21.4 0 0.0 0 0.0
Medication
Antidepressants 8 57.1 0 0.0 1 7.1
Anxiolytics 1 7.1 0 0.0 1 7.1
Opioids 1 7.1 0 0.0 1 7.1
*Chi-square test, Fisher’s exact test or analysis of variance when appropriate.
aCompensation by the insurance.
bMultiple diagnosis possible.
PTSD, posttraumatic stress disorder; SD, standard deviation.
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of RA (Arnett et al., 1988). Dolorimetry was performed at 24
tender points (for classification 12/24 with 2 kg/
1.27 cm2) and eight control points (for classification 3/8)
(Dettmer and Chrostek, 1991). The method we adopted has
been described elsewhere (Wolfe, 1997).
Psychiatric diagnoses were established with the Mini
International Neuropsychiatric Interview (Sheehan et al.,
1998), which is a short structured diagnostic interview for 17
Axis-I diagnoses according to the Diagnostic and Statistical
Manual of Mental Disorders, version IV and the Interna-
tional Classification of Diseases-10 criteria. The FMS and RA
subjects were recruited through the outpatient clinical ser-
vices of the Department of Rheumatology of Zurich Univer-
sity Hospital, and the HC were recruited by advertisements in
local newspapers. The clinical evaluation included electro-
cardiography (ECG) and laboratory tests. Exclusion criteria
included major medical illnesses other than FMS and RA,
pregnancy, psychosis, suicidal ideation or suicide attempts
within the previous 8 weeks, substance abuse within the past
year, and a lifetime history of substance dependence. Prior to
the experiment, clinical characteristics were assessed with
the State-Trait Anxiety Inventory (Laux and Vossel, 1982),
the Beck Depression Inventory (Beck et al., 1994) and the
Pain Disability Index (Tait et al., 1990; Dillmann et al.,
1994). The Pain Disability Index measures pain-related inter-
ference with role functioning in seven areas (occupational,
home/family, recreational, social, sexual, activities of daily
living and life support), which are all rated on 11-point
Likert-type scales (0, no disability; 10, complete disability).
The average ongoing chronic pain, which was defined as the
average pain that subjects had suffered during the 2 weeks
prior to the measurement, was assessed with a visual ana-
logue scale (VAS) that went from 0 (no pain) to 100 (worst
possible pain).
2.3 Pain stimuli
Thermal stimuli were applied to the thenar of the non-
dominant hand with a 27-mm-diameter thermal contact
thermode (CHEPS, Medoc Ltd, Ramat Yishai, Israel). The
CHEPS thermode has a heating rate of 70 °C/s and a cooling
rate of 40 °C/s. The same heating and cooling rate was
applied during the whole experiment. Pain threshold esti-
mation was based on five thermal stimuli that slowly
increased in temperature (1 °C/s) until it was stopped by a
button press or when the maximum temperature of 52 °C
was reached. In the second step, a temperature that was
rated as moderate pain (approximately 50 mm on the VAS)
was individually assessed for each subject and used as the
low-temperature stimulus (USlow). The temperature that was
established for USlow was increased by 2.5 °C to obtain the
high-temperature stimulus (UShigh). This substantial increase
in temperature has been found to clearly discriminate
between UShigh and all other painful stimulations (Ploghaus
et al., 2001). UShigh was only presented during the experi-
ment itself. There was a 30-min interval between the pain
threshold estimation and the conditioning experiment.
2.4 Protocol
No explicit information about the CS–US relationship was
given to the participants prior to conditioning. Prior to the
experiment, subjects were instructed that they would see
shapes on the screen and feel heat bursts on their hand.
Thermal stimulation and the recording of physiologic activity
(heart rate, HR) was controlled by a commercial device (Pre-
sentation software, Neurobehavioral Systems, Inc., Albany,
CA, USA). Visual stimuli (simple black squares and triangles
on a white background) were presented on a monitor that
was located 2 m in front of the subjects. Subjects were pre-
sented thermal stimuli of different temperatures for a dura-
tion of 6 s. During the experiment, the perceived pain
intensity and fear levels were assessed with a VAS that con-
sisted of a 100-mm line that was anchored from 0 (no pain)
to 100 (worst possible pain) and 0 (no fear) to 100 (maximal
fear) (Scott and Huskisson, 1976). It was explained to the
subjects that the pain ratings explicitly concerned their per-
ceived sensory intensity and not the unpleasantness of the
pain. The levels of fear that were explained to be related to
the CS (and not to the pain) were used to measure whether
the conditioning was successful or not. The scale was pre-
sented for a period of 5 s after the offset of the thermal
stimulus.
The experimental paradigm, which is displayed in Fig. 1,
used delay-conditioning contiguities. The whole paradigm
consisted of 20 trials with 10 for each condition (CS-, CS+).
One visual signal (CS-) was always followed by the USlow.
This signal came to evoke low fear about the impending pain.
The other visual signal was followed in a pseudorandomized
way in half of the trials by USlow (CS+low) and in the other half
of the trials by the higher temperature pain stimulus, UShigh
(CS+high). This signal (CS+high) came to elicit higher fear about
the impending pain. The delay between signal onset and the
onset of thermal stimulation (CS–US interval) was random-
ized with a range between 8 and 15 s in order to make the
CS–US associative learning more efficient. The intertrial
interval was 30 s.
2.5 Heart rate
HR was continuously recorded simultaneously with a
Lifeshirt-System® (VivoMetrics® Inc., Ventura, CA, USA).
The device, which applies a proprietary algorithm to detect
the peak of the R-wave from the digitized ECG, has been
shown to be highly accurate in the detection of R-waves and
in providing an accurate timing of R–R intervals (Heilman
and Porges, 2007). The LifeShirt samples the ECG at 200 Hz.
R-waves were detected in the digitized ECG, and interbeat
intervals (cardiac time) were converted to beats per min
(BPM, real time) every 500 ms. BPM during the first 8 s of
the CS were analysed s-by-s and were expressed relative to
the baseline that was taken during a 1-s window before CS
onset. BPM changes were then converted back into HR
changes, which were computed by subtracting HR during the
s before CS (i.e., the last s of the intertrial interval) from the
Fear-learning deficits in fibromyalgia syndrome J. Jenewein et al.
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HR during the highest acceleration within the CS (i.e.,
between the fourth and seventh second).
2.6 Contingency learning
Following the experiment, contingency awareness was
assessed by asking the subjects which of the two visual cues
(CS+ and CS-) had previously been associated with the
painful high-temperature stimulation. If the subjects
reported that they were completely or fairly certain that the
CS+ was paired with the high-temperature stimulus and CS-
was not paired with the high-temperature stimulus, they
were considered aware.
2.7 Data analysis
In order to analyse the self-reported experiences of pain
intensity, fear and the HR data, linear mixed-model analyses
were computed with SPSS 19 for Windows (IBM Corpora-
tion, Armonk, NY, USA). Group differences in the pain and
fear ratings, as well as the HR responses, were tested with full
factorial models with group and signal (type of CS) or group
and temperature (type of US) as fixed factors. Interaction
effects were used to evaluate the differences in the reactions
and responses between the groups. The model-predicted
estimated marginal means of the measures in each group
allowed for comparisons of the levels of signal and tempera-
ture. In all models, a first-order autoregressive covariance
structure was appropriate for the repeated measures. A
restricted maximum likelihood model estimation was used.
The significance level was set to p < 0.05.
In order to evaluate the effects of contingency learning
(i.e., predictability of the impending stimulus) on pain per-
ception, only CS- and CS+low trials (i.e., CS followed by
low-temperature US) were used. The reason for excluding
CS+high trials was that pain and fear were assessed retrospec-
tively, and they therefore would have potentially biased the
comparison of CS- and CS+ ratings and one of the main
questions of this study, which was whether the same pain
stimulus (USlow) would be rated differently depending on the
condition (CS-, CS+). CS+high trials were included in all other
mixed-model analyses. This was because the effects of tem-
perature on the pain ratings and HR responses could be
tested only when the high-temperature stimuli were
included and because HR responses directly following the CS
were supposed to be unbiased by the subsequently applied
heat bursts. Because there was no learning history before the
first trial, it was consistently excluded from the data analyses.
3. Results
3.1 Pain stimuli and awareness of
CS–US relationship
The mean temperature for the USlow stimulus was
46.26 °C (SD, 1.20) for the FMS subjects, 46.98 °C
(SD, 0.29) for the RA subjects, and 46.99 °C (SD, 0.55)
for the HC group (F, 3.98; df, 2, 39; p = 0.03). At the
end of the conditioning experiment, only 7 out of the
14 (50%) FMS subjects reported that they were com-
pletely or fairly certain that the CS+high signal was paired
with the higher temperature stimulus (UShigh) and
were designated aware (see Fig. 2 for the learning
curves). In 12 out of the 14 (86%) RA subjects and in
the whole (100%) HC group, the subjects were aware
of the meanings of the conditioned signals. Accord-
ingly, awareness significantly differed between the
diagnostic groups (Fisher’s exact test, p = 0.005).
Based on our hypothesis, we expected an increased
rate of unaware FMS subjects because of their fear-
learning deficits, and we did not exclude them from
further analyses. There was no association between
awareness and psychiatric co-morbidities in the FMS
Figure 1 Experimental paradigm and time
course of the conditioning experiment. Experi-
mental paradigm (top): Visual cues predicted
exposure to painful heat stimulation. Painful
stimulation was delivered at a low temperature
(LT) or at a higher, more painful temperature
(HT). One visual cue (here: triangle) was consis-
tently followed by a LT. Another cue (here:
square) was followed by LT or HT. LF: low fear/
pain signal (CS-); HF: high fear/pain signal
(CS+low or CS+high). The conditioned stimuli
were presented during a variable amount of
time (8 to 15 s) in order to increase the unpre-
dictability of the unconditioned stimuli. The
duration of the exposure to heat stimulation
was 6 s. Self-reported fear and pain ratings
were assessed in the intertrial intervals of 30 s.
CS, conditioned stimulus; US, unconditioned
stimulus.
J. Jenewein et al. Fear-learning deficits in fibromyalgia syndrome
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group (Fisher’s exact test, p = 0.63). In the FMS group,
10 of the 14 patients were being treated with psycho-
tropic substances. However, there was no association
between awareness and medication (Fisher’s exact
test, p = 0.56).
3.2 Effect of CS on anxiety and
pain experience
The ratings of subjective pain and fear perception as
assessed by the VAS during the conditioning experi-
ment are presented in Fig. 3 as well as in Tables 2
and 3 (means and standard deviations of self-reported
fear and pain after CS-/low-temperature stimulation,
CS+/low-temperature stimulation and CS+/high-
temperature stimulation). Mixed-model analyses that
Figure 2 Learning curves. Self-reported fear ratings after each trial clas-
siﬁed by diagnostic group and kind of CS stimulus. The panels illustrate
adaptive differential conditioning by higher fear responses to CS+ than to
CS- in healthy controls and rheumatoid arthritis subjects, but not in ﬁbro-
myalgia subjects. Error bars indicate standard errors of means (SEM).
Figure 3 Behavioural results. The means of the self-reported fear and
pain ratings after CS-/low-temperature stimulation, CS+/low-temperature
stimulation and CS+/high-temperature stimulation classiﬁed by diagnostic
group (14 ﬁbromyalgia subjects, 14 healthy controls, 14 rheumatoid
arthritis subjects). Error bars indicate standard errors of means (SEM).
Table 2 Means and standard deviations of pain and fear rating, and heart
rate changes of subjects with ﬁbromyalgia (n = 14), healthy controls
(n = 14) and rheumatoid arthritis (n = 14).
Variable
Fibromyalgia Healthy control Arthritis
Mean SD Mean SD Mean SD
Fear
CS- 25.8 25.1 18.5 14.1 15.2 11.2
CS+low 22.8 20.6 30.4 20.7 18.2 15.0
CS+high 26.9 24.8 30.9 21.1 23.0 14.7
Pain
CS- 41.2 20.5 33.6 20.7 32.4 18.4
CS+low 41.9 19.6 40.5 25.0 36.7 21.3
CS+high 76.7 16.8 70.3 22.5 64.5 19.8
HR change (bpm)
CS- 3.75 4.74 4.23 4.68 4.10 5.35
CS+ 4.44 4.75 5.28 4.85 4.62 4.91
CS, conditioned stimulus; HR, heart rate; SD, standard deviation.
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were used to examine the effects of the group and the
type of conditioned stimulus (CS- vs. CS+low) on fear
and pain ratings revealed significant interaction effects
between group and the type of CS on both ratings
(fear: F, 42.1; df, 2, 343.0; p < 0.001; pain: F, 6.27;
df, 2, 356.1; p = 0.002), indicating that the diagnostic
groups showed significantly different patterns of fear
and pain responses to CS presentation, which corre-
sponded to our hypothesis. Pairwise comparisons of
the estimated marginal means revealed that fear and
pain experiences differed significantly between CS-
and CS+low in HC (fear: F, 127.9; df, 1, 346.7;
p < 0.001; pain: F, 37.8; df, 1, 356.1; p < 0.001) and RA
(fear: F, 11.4; df, 1, 341.2; p < 0.001; pain: F, 15.7; df,
1, 356.1; p < 0.001), but not in the FMS group (fear: F,
2.26; df, 1, 341.2; p = 0.13; pain: F, 1.33; df, 1, 356.1;
p = 0.25). Thus, the low-temperature stimulation was
experienced as less painful when it was predicted by
the CS- (safety cue) in the HC and the RA group but
not in the FMS group. Even after excluding the
unaware FMS subjects (n = 7), the responses to CS-
and CS+low were not statistically different (fear: F, 0.12;
df, 1, 276.1; p = 0.73; pain: F, 2.42; df, 1, 277.4;
p = 0.12; Table 3).
The average ongoing chronic pain rating in the FMS
group was 7.1 (SD, 1.3), and it was 4.6 (SD, 2.4) in the
RA group. There was no significant difference regard-
ing the ongoing chronic pain rating between the
aware and unaware FMS subjects (t, -0.19; df, 12;
p = 0.85). In the FMS or in the RA groups, ongoing
pain did not correlate significantly with pain or fear
ratings during each trial.
3.3 Effect of US on pain experience
There was a significant main effect of the type of US
(low vs. high temperature) on self-reported pain (F, 1,
086.1; df, 1, 598.5; p < 0.001) and a non-significant
interaction effect between subject group and the type
of US in this mixed-model analysis (F, 1.75; df, 2,
598.5; p = 0.17), suggesting that, in all diagnostic
groups, high-temperature stimulation induced higher
pain experience than low-temperature stimulation.
3.4 Heart rate during CS
The HR changes during each CS are shown in Fig. 4.
The maximum changes were calculated as the highest
acceleration between 4 and 7 s post-CS. The means
and SDs of the HR changes that were related to con-
ditioned stimuli (CS- and CS+) are reported in Table 2.
The group-by-CS type interaction was not significant
(F, 0.33; df, 2, 580.3; p = 0.72), while the main effect
of CS type was significant (F, 6.91; df, 1, 580.3;
p = 0.009), indicating that the acceleration of HR after
CS+ was more or less similar in all diagnostic groups.
After excluding the unaware FMS subjects from the
analysis, there was a significantly increased HR change
in the aware FMS subjects after CS+ compared to CS-
(F, 4.89; df, 1, 468.4; p = 0.03). In contrast, unaware
FMS subjects showed no such difference (F, 0.09; df, 1,
471.4; p = 0.77; Table 3).
4. Discussion
Consistent with the findings of the study by Ploghaus
et al. (2001), HCs and subjects with RA experienced
Table 3 Means and standard deviations of pain and fear rating, and heart
rate of subjects with ﬁbromyalgia: Comparison of aware (n = 7) with
unaware subjects (n = 7).
Variable
Aware Unaware
Mean SD Mean SD
Fear
CS- 17.4 17.0 34.3 28.9
CS+low 17.9 9.7 27.7 26.8
Pain
CS- 36.0 15.7 46.4 23.4
CS+low 38.6 15.6 45.1 22.7
Heart rate change
CS- 4.77 5.62 2.72 3.40
CS+ 6.37 5.00 2.51 3.61
CS, conditioned stimulus; SD, standard deviation.
Figure 4 Heart rate results. Heart rate changes during the conditioned
stimuli CS+ and CS-. The panels illustrate the heart rate change wave-
forms for the CS+ and CS- trials. Because the present study used a range
of CS–US intervals (8–15 s), only the initial 8 s were used to estimate heart
rate responses to the CS. The time point 0 s represents the s before CS
onset. Heart rate responses of aware (7) and unaware (7) FMS subjects
were analysed separately.
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less fear following CS- than following CS+, and they
experienced exposures to low temperature as less
painful when presented after CS- than after CS+.
These results demonstrated that the experience of pain
may be modulated by fear. Consistent with our
hypothesis, subjects with FMS showed deficits in con-
tingency learning at the behavioural and physiological
level (HR). Most likely, because they did not know
which CS predicted the high temperature, the CS-
induced the same level of fear as the CS+. Unlike the
control and RA groups, the experience of the low-
temperature stimulation in the FMS group was not
modulated by the CS. Specifically, they showed
increased levels of pain during the CS-low, probably
because the CS- did not act as a safety cue.
Conditioning theories provide a conceptual frame-
work for understanding reactions to threats, assuming
that learning is based on the information value of
predictive cues and that fear/anxiety is based on
expectancy about the occurrence of aversive events
(Mathews and MacLeod, 1985). Perceived unpredict-
ability, which is the failure to learn about the contin-
gency, is fundamental to sustained anxiety (Grillon
et al., 2004) and to an increase in contextual anxiety
(Grillon, 2002). Deficits in the learning about contin-
gencies in the environment make the environment
unpredictable, which is anxiogenic and may contrib-
ute to increased chronic pain perception. Additionally,
unpredictability may contribute to hyperalgesia in
FMS subjects, given the strong relationship between
FMS and anxiety (Asmundson and Katz, 2009) and
the increased reactivity to threat-related pictures in
these individuals (Bartley et al., 2009). The origin of
perceived unpredictability is still obscure. In condi-
tioning experiments, subjects with trait anxiety have
shown slower rates at the cognitive (awareness) and
physiological (skin conductance) level for differentiat-
ing between CS+ and CS- than do control subjects
(Chan and Lovibond, 1996). This learning deficit is
associated with a bias towards a higher expectancy of
aversive events. Subsequent studies have shown that
deficits in explicit cue fear conditioning result in an
increased perception of unpredictability, enhanced
physiological signs of anxiety and behavioural avoid-
ance (Grillon, 2002). Such a learning deficit may
conceivably contribute to attentional bias, anxiety
sensitivity, avoidance, reduced activity levels and
higher pain levels in FMS subjects (Asmundson and
Katz, 2009). Evidence from neuroimaging studies
seems to confirm a shared pathogenic mechanism in
anxiety and pain regarding the perception of unpre-
dictability. In healthy volunteers, the anticipation of
unpredictably administered electric shocks induces
sustained anxiety along with an increase in blood flow
in the hippocampus (Hasler et al., 2007). In the
Ploghaus study (Ploghaus et al., 2001) on anxiety-
induced hyperalgesia, hippocampal activation was
associated with an exacerbation of pain by anxiety in
healthy volunteers. In FMS subjects, a recent imaging
study that used magnetic resonance diffusion-tensor
imaging and voxel-based morphometry found micro-
structural changes in the bilateral hippocampi (Lutz
et al., 2008). In addition, they found structural abnor-
malities in the amygdala, which plays a central role in
explicit cue fear conditioning (Buchel and Dolan,
2000). These findings support our hypothesis that
fear-related mechanisms might play an important role
in FMS pathogenesis.
Another explanation for our findings is that the
repeated administration of thermal stimuli in the FMS
subjects resulted in central sensitization. Therefore,
over time, their perceived intensities of the nocicep-
tive stimulus increased (Clifford, 2011). However, this
explanation is not likely true because there was
no increase in the perceived pain intensity in FMS
subjects.
The strengths of our study include the relatively
close matching among the diagnostic groups regarding
gender, age and group size and the inclusion of a
positive control group with RA, which represents a
chronic pain condition other than FMS and allows for
evaluating the specificity of the results for FMS. The
conditioning experiment described by Ploghaus et al.
(2001) was well suited for studying the pathophysiol-
ogy of FMS because the use of pain as an US is likely
relevant in FMS subjects and the experiment allowed
for the examination of pain exacerbation by anxiety.
This study has several methodological limitations.
While Ploghaus et al. (2001) obtained fear and pain
ratings in separate groups of subjects, we obtained
these ratings in the same-subject groups because of the
difficulty in recruiting two samples of FMS subjects.
Hence, the self-report assessments of both processes in
the same subject may have led to an overestimation of
pain–fear correlations. Because the pain- and fear-
rating data in HCs in this study were similar to those in
the Ploghaus study, bias due to our rating method
seems unlikely. Additionally, fear ratings may not only
reflect fear related to theCS, butmay also be influenced
by general anxiety or uncertainty in the experiment.
Further, this was not a traditional differential condi-
tioning study becausewe did not use a true safety signal
(no pairingwith theUS). Becausewewere interested in
the influence of fear on pain experience in different
conditions,we used a low-temperature stimulus for the
CS- condition. Another concern is the clinical hetero-
Fear-learning deficits in fibromyalgia syndrome J. Jenewein et al.
8 Eur J Pain •• (2013) ••–•• © 2013 European Federation of International Association for the Study of Pain Chapters
geneity of the FMS sample as more than half the FMS
subjects had co-morbid anxiety or depressive disorder,
which corresponded to the co-morbidity pattern found
in representative samples. Given that learning deficits
have been reported for individuals with anxiety disor-
ders (Lissek et al., 2009) and that subjects with major
depressive disorder show abnormal reactivity during
the anticipation of heat pain (Strigo et al., 2008), spe-
cific pathogenic mechanisms underlying FMS may not
have solely contributed to the fear-learning deficits
found in this group. Consistent with the high preva-
lence of psychiatric disorders among FMS subjects, nine
subjects in the FMS group were being treated with
antidepressant drugs and one was being treated with
anxiolytic drugs, which may additionally have influ-
enced fear conditioning. We did not, however, find an
association between the presence of psychiatric
co-morbidities and the awareness of the CS–US
relationship in our FMS sample (Fisher’s exact test,
p = 0.63). Additionally, there was no association
between awareness andmedication (Fisher’s exact test,
p = 0.56). We found no correlations between the levels
of ongoing chronic pain and the fear ratings during the
experiment in the FMS group and the RA group, sug-
gesting that chronic pain may not have interfered with
fear conditioning. Another concernwas thatwe did not
specifically test neuropsychological deficits, which
could be related to the awareness deficits in the FMS
group. The RA subjects may not represent an ideal
control croup because they have a higher prevalence of
mental disorders than the general population (Lok
et al., 2010). However, in this study, RA subjects had a
relatively low rate of psychopathology.
The failure of contingency learning associated with
increased pain experience in FMS subjects suggested
that fear-learning deficits play an important role in the
FMS pathogenesis. When a danger signal (CS+) pre-
dicts a painful experience, the absence of the danger
signal (e.g., context) predicts periods of safety. Sub-
jects who are unable to identify danger signals (or are
unable to learn safety cues) remain in a chronic state
of fear because they cannot identify safety periods. In
this model, fear conditioning is a process in which
generalized fear of the context becomes stimulus spe-
cific and predictable. Fear remains generalized when
aversive events occur unpredictably or when subjects
fail to identify stimulus contingency (Grillon and
Davis, 1997). In FMS subjects, a sustained and exces-
sive anticipation of unpredictable painful events
(bodily symptoms or external events) may contribute
to the experience of chronic and widespread pain, low
levels of physical activity and dependence on the rela-
tively predictable effects of pain-contingent analgesics.
FMS subjects did not report significantly more fear
and pain in the CS+high condition than the HCs did
(p = 0.26, p = 0.27, respectively); this would have
been a direct demonstration of fear-learning deficits
causing excessive fear and hyperalgesia. However, our
study was not designed to show such relationships.
Painful stimuli (US) were adjusted for each subject to
her individual pain threshold, resulting in systemati-
cally less intense stimulation in FMS subjects than in
HCs and RA subjects, which is a confounding factor
when comparing pain and fear across groups. There-
fore, we focused on the differential fear and pain
response, which showed significant group differences.
Qualitatively, the results on pain that are displayed in
Fig. 3 suggested that fear-learning deficits result in
relatively more pain in the CS- condition in FMS
subjects than in HCs and RA subjects. Furthermore,
when we analysed aware and unaware FMS subjects
separately, unaware FMS subjects reported higher fear
and pain ratings than did aware FMS, HCs and RA
subjects (Tables 2 and 3). Aware FMS subjects,
however, showed higher HR acceleration compared
to the other groups, suggesting an enhanced and
sustained fear of pain.
This study encouraged the use of neuroimaging
techniques to elucidate the neural substrate of fear-
learning deficits and anxiety-induced hyperalgesia in
FMS. Based on the studies by Hasler et al. (2007) on
unpredictability and Ploghaus et al. (2001) on
anxiety-related hyperalgesia and the structural
imaging work in FMS (Lutz et al., 2008), one may
hypothesize that a hippocampal network is impor-
tantly involved in fear-related mechanisms in the
pathogenesis of FMS. Moreover, the results of this
study may translate into the development of specific
therapeutic approaches to FMS. Given the evidence in
animals that D-cycloserine enhances the ability to
discriminate between conditioned danger cues and
conditioned safety cues (Land and Riccio, 1999),
D-cycloserine may enhance conditioning discrimina-
tion and reduce unpredictability and anxiety-related
pain in FMS subjects.
In summary, fear-learning deficits represent a
potentially promising and specific, but largely
unstudied, psychopathological marker in FMS. Con-
sistent with our predictions, the ability of FMS sub-
jects to differentiate between a cue predicting a risk
of painful thermal stimulation and a safety cue led to
relatively increased fear and pain in the context of
the safety cue. The findings of this study may con-
tribute to elucidating the pathophysiology of FMS
and may lead to the development of novel therapeu-
tic approaches.
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